Official Press Releases
4D Approach to Examining Structural and Functional Changes of Proteins Published in International Computational Intelligence Book SAN DIEGO, CA – December 7, 2017: CureMatch Co-Founders Igor F. Tsigelny, Ph.D. and Razelle Kurzrock, M.D. along with colleagues from UC San Diego and University of Bergen have authored a personalized cancer medicine study examining activation of protein complexes […]
LISBON, PORTUGAL – CureMatch is proud to announce that CureMatch Chief Technology Officer and co-founder, Igor Tsigelny, PhD was invited in November as a plenary speaker to the PCS 4th Annual Global Cancer Conference-2017 in Lisbon, Portugal. The international meeting focused on basic research and clinical cancer research. Presentations and discussions concerning top cancer killers […]
New cancer research titled “BRAF Mutation as a Novel Driver of Eosinophilic Cystitis” was recently published in the Cancer Biology & Therapy Journal and includes work by CureMatch Co-Founders Igor F. Tsigelny, Ph.D. and Razelle Kurzrock, M.D. along with colleagues from the San Diego Supercomputer Center and UCSD Moores Cancer Center. This article highlights the role of a specific molecular mutation in eosinophilic cystitis, a rare inflammatory bladder condition. Genetic markers such as BRAF I463T provide some of the best indicators to recommend personalized treatments and improve survival rates.
SAN DIEGO, CA – August 18, 2017 –CureMatch, a digital health company focusing on personalized medicine and combination therapy in oncology, today announced that it has closed its bridge round to Series A financing. CureMatch is the only company to offer a data-driven report that scores combinations of cancer drugs that are tailored for individual patients. The report is generated using CureMatch’s Decision Support System, which analyzes millions of cancer treatment options with its proprietary algorithms and evidence-based, custom-curated databases of genomics and proteomics information.
SAN DIEGO, CA – CureMatch is pleased to announce it has been selected to take part in MetroConnect 2017, an export assistance program run by the World Trade Center San Diego (WTC) and designed to help San Diego companies accelerate their global growth. The announcement will be made today by San Diego Mayor Kevin Faulconer and WTC San Diego.